• INTERSTELLAR LAB

  Led · Seed · Sep 2021

  Interstellar Lab develops and constructs closed-loop sustainable living systems, including space-grade food production systems and habitat modules. The company aims to address Earth's climate crisis by generating and recycling food, water, and air while also developing life-support systems for lunar missions and future Mars exploration in the context of NASA's Artemis Program. Interstellar Lab positions its technology as both a solution for resource-conscious agriculture on Earth and as a testbed for sustaining human life in space. The company's recent financing activity included a seed round used to advance development and validation of its systems. FII Institute invested in the company to support development work and to leverage AI simulation-based designs for waste management, zero-impact living, and resource-conscious agriculture.

• Healthware

  Led · Equity · Feb 2019

  Healthware is an integrated consulting group based in Milan and Salerno, Italy that supports marketing and sales in life sciences and digital health. Led by CEO and founder Roberto Ascione, it offers services combining design, strategy, communication and innovation with technology and corporate venturing at the intersection of commercial operations transformation and digital health. The company and its US joint‑venture partner Intouch Group together form one of the largest global independent consultancies, with a combined team of more than 1,000 specialists and offices in New York, Boston, Kansas City, Chicago, London, Cologne, Milan, Rome, Salerno and Mumbai. In April 2019 Healthware raised €10m in funding. The capital increase will reinforce the company’s verticals focused on business transformation for life sciences companies and product development and services for digital health start‑ups. Focus areas include digital health platforms, digital therapeutics, health insurance and AI applications.

• Leadza

  Led · Equity · Nov 2018

  Leadza provides AI-driven optimization for ads in social networks, automating ad performance improvements. The company positions its product to help advertisers improve campaign effectiveness via artificial intelligence. According to the report, Leadza plans to spend the newly raised funds on promotion in the U.S. market. The startup raised 19 million rubles (about $300k) in the reported financing. The article includes reader commentary debating whether that amount is sufficient for U.S. expansion.

• Data MATRIX

  Led · Equity · Dec 2016

  Data Matrix developed Russia's first software for organizing and managing clinical trials in accordance with global standards. The company provides data-processing and biostatistics services and is building cloud-based clinical-trial software. Its solution is designed to accelerate drug and medical-device development while reducing errors, handling patient randomization, supply management, data collection and safety monitoring. Planned future modules will add financial tracking, quality control, project management and other features. Data Matrix is a resident of the Skolkovo biomed cluster and has completed more than 100 projects for major pharma and biotech clients, including Evalar, GlaxoSmithKline and Novartis. The startup recently secured ₽160M in investments to further develop the system and expand into foreign markets, with FRII providing the majority of the funding.

No current team members are available.